Philadelphia Business Journal January 3, 2013 Discovery Labs launches Afectair, Surfaxin in the wings
Philadelphia Business Journal January 3, 2012 Discovery Labs extends lease at Warrington HQ
Philadelphia Business Journal October 5, 2012 Discovery Labs Named Life Sciences Company of the Year
NEONATOLOGY TODAY July 2012 Issue Table of Contents, Volume 7 / Issue 7 http://www.neonatologytoday.net/newsletters/nt-jul12.pdf
May 15, 2013 Discovery Labs Announces Completion of $14.25 Million Public Offering
May 10, 2013 Discovery Labs Prices $14.25 Million Public Offering of Common Stock
May 9, 2013 Discovery Labs Announces Proposed Public Offering of Common Stock
May 7, 2013 Discovery Labs Reports First Quarter 2013 Financial Results
May 1, 2013 Discovery Labs Announces Recent AFECTAIR® Publications
Apr 15, 2013 Discovery Labs Receives FDA Recommendations and Request for Clarification Regarding Recently-Submitted SURFAXIN® (lucinactant) Updated Product Specifications
Mar 29, 2013 Discovery Labs Announces Newly-Released SURFAXIN® (lucinactant) Publications
